Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1399 studies found for:    "Kidney cancer"
Show Display Options
Rank Status Study
1 Unknown  Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Interventions: Biological: therapeutic allogeneic lymphocytes;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Procedure: allogeneic bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation
2 Unknown  Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Interventions: Drug: doxorubicin hydrochloride;   Drug: ifosfamide
3 Completed ZD 1839 in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Intervention: Drug: gefitinib
4 Completed PS-341 in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Interventions: Drug: PS-341;   Procedure: Tumor Biopsy
5 Withdrawn Talabostat in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Interventions: Drug: talabostat mesylate;   Procedure: diagnostic procedure;   Procedure: enzyme inhibitor therapy;   Procedure: flow cytometry;   Procedure: laboratory biomarker analysis;   Procedure: non-specific immune-modulator therapy
6 Completed Dolastatin 10 in Treating Patients With Advanced Kidney Cancer
Condition: Kidney Cancer
Intervention: Drug: dolastatin 10
7 Completed Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Intervention: Drug: bryostatin 1
8 Completed AE-941 in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Intervention: Drug: shark cartilage extract AE-941
9 Unknown  Interleukin-2 in Treating Patients With Metastatic or Recurrent Kidney Cancer
Condition: Kidney Cancer
Interventions: Biological: aldesleukin;   Procedure: conventional surgery
10 Completed Arsenic Trioxide in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Intervention: Drug: arsenic trioxide
11 Completed PS-341 in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Intervention: Drug: bortezomib
12 Completed RPI.4610 in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Intervention: Biological: anti-FLT-1 ribozyme
13 Completed Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Interventions: Drug: capecitabine;   Drug: gemcitabine hydrochloride
14 Completed
Has Results
Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer
Condition: Kidney Cancer
Intervention: Drug: sunitinib malate
15 Completed Vaccine Therapy in Treating Patients With Advanced Kidney Cancer
Condition: Kidney Cancer
Interventions: Biological: dendritic cell vaccine therapy;   Procedure: conventional surgery
16 Completed ZD 1839 in Treating Patients With Stage IV or Recurrent Kidney Cancer
Condition: Kidney Cancer
Intervention: Drug: gefitinib
17 Completed Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Interventions: Drug: cisplatin;   Drug: gemcitabine hydrochloride
18 Unknown  Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Interventions: Biological: aldesleukin;   Biological: recombinant interferon alfa;   Procedure: conventional surgery
19 Completed Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer
Condition: Kidney Cancer
Intervention: Drug: atrasentan hydrochloride
20 Completed 6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Intervention: Drug: irofulven

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.